Back

Medscape, LLC

  • Cardiomyopathy, Hypertrophic

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: From Fast Facts to Patient-Centered Solutions_Chen

The goal of this activity is for learners to be better able to discuss integration of new and potential emerging HCM treatments into clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Dec 2, 2025
  • Last day to claim credit
    Dec 3, 2026 8 weeks left